Posts

Showing posts with the label JAMA Health Forum New Online

Ebola and the Catastrophic Cost of Public Health Infrastructure Disinvestment

This JAMA Forum discusses aspects of the Ebola outbreak, including erosion of disease surveillance, transactional global health security, and cost inefficiencies. from JAMA Health Forum New Online https://ift.tt/4Y5JfdL

School Vaccination Requirements as Preventive Care Infrastructure

This Viewpoint explores how school-entry vaccine requirements provide an unusually valuable point of contact between the education system and the health care system. from JAMA Health Forum New Online https://ift.tt/nZj79gm

Five Building Blocks for Creating a Bipartisan Post–Trump US Health Care System

This JAMA Forum discusses ideas ranging from direct subsidies to better Affordable Care Act health exchanges as potential ways to reform and improve the health care system in the US. from JAMA Health Forum New Online https://ift.tt/8hVZYrz

The AI Regulatory 2-Step and Implications for Responsibilities of Health Systems

This Viewpoint discusses regulatory concerns surrounding the use of artificial intelligence (AI) in health care and outlines how health systems can responsibly adopt AI in a policy vacuum. from JAMA Health Forum New Online https://ift.tt/QvOEbqh

Losing Our Lens on Maternal and Infant Health—The Consequences of Disrupting PRAMS

This JAMA Forum discusses the importance of the Pregnancy Risk Assessment Monitoring System (PRAMS) for maternal and infant health, recent changes that threaten PRAMS, and implications for health professionals, the public, and policymakers. from JAMA Health Forum New Online https://ift.tt/z9x3rQu

Alternative Payment Models in Inpatient Psychiatry

This Viewpoint discusses per diem vs diagnosis-related group–based payments in psychiatric care and outlines alternative payment models to better balance access, quality, and efficiency. from JAMA Health Forum New Online https://ift.tt/u1Si20H

Why Do We Hear More About High Drug Prices Than About Hospital Prices?

This JAMA Forum discusses the potential reasons why high drug prices get more attention in US society than high hospital prices. from JAMA Health Forum New Online https://ift.tt/19HqGV7

Protecting At-Risk Families From Secondhand Smoke at Home

This Viewpoint describes how the World Health Organization (WHO) Framework Convention on Tobacco Control recommendations create an opportunity to extend protection from secondhand smoke to private and semiprivate residential spaces and, thus, improve health and housing equity. from JAMA Health Forum New Online https://ift.tt/nKXGj7w

Why AI’s Mental Health Risks Demand Regulation Now

This JAMA Forum discusses societal problems associated with artificial intelligence (AI), the pathways in which AI programs were created and implemented, and potential solutions and regulatory recommendations to reduce AI harms. from JAMA Health Forum New Online https://ift.tt/0yY4B5t

Medicaid Expansion and Mortality Among Formerly Incarcerated Individuals

This cross-sectional study reports on the association of mortality in formerly incarcerated individuals after the Affordable Care Act allowed states to expand Medicaid coverage. from JAMA Health Forum New Online https://ift.tt/TYFf14x

Home- and Community-Based Services Spending and Living Arrangements Among Older Adults

This cross-sectional study examines the association between higher state allocation of long-term care spending to home- and community-based services and the likelihood of group quarters residence, coresidence with adult children, Medicaid enrollment, and migration among older adults with and without independent living difficulties. from JAMA Health Forum New Online https://ift.tt/sZ5qeuJ

JAMA Health Forum

Health Policy from JAMA Health Forum New Online https://ift.tt/0nSeFY4

Ultralow-Volume Treatments for Mosquito-Borne Diseases

This Viewpoint discusses ultralow-volume treatments composed of organophosphates and pyrethroids for mosquito management, which can help prevent and control mosquito-borne disease outbreaks. from JAMA Health Forum New Online https://ift.tt/XrFyf13

Exposure to Hurricane-Related Flooding and Outcomes of Home Health Care Patients

This cohort study assesses the convergence of the rising threat of extreme weather events and increasing use of home health care through the lens of Hurricane Sandy. from JAMA Health Forum New Online https://ift.tt/2uRmj5c

GLP-1 Prescriptions for Weight Loss by Differences in Insurance Plan Coverage

This cross-sectional study reports trends in glucagon-like peptide-1 (GLP-1) prescriptions for plans that do and do not cover GLP-1s for weight loss. from JAMA Health Forum New Online https://ift.tt/iHGAmFM

Geographic Availability and Use of Medications for Opioid Use Disorder Among Medicaid Enrollees

This cross-sectional study examines the association between racial and ethnic differences in the use of medication for opioid use disorder and geographic availability of such medication. from JAMA Health Forum New Online https://ift.tt/AvUPTiG

Scoring Health Reform

This Viewpoint discusses the scoring system used by the Congressional Budget Office for health policy decisions and explores the long-term consequences that receive inadequate analysis within this system. from JAMA Health Forum New Online https://ift.tt/1EZ6IDU

Making Policy When the Perfect Is Impossible

This JAMA Forum discusses ethical and economic aspects of allocating resources in the context of cuts made to Medicaid under the Budget Reconciliation Act of 2025. from JAMA Health Forum New Online https://ift.tt/MOspmWx

Clinical AI—Whom Does It Serve and Who Pays?

This Viewpoint proposes that routine adoption of clinical artificial intelligence (AI) requires explicit alignment of payer, primary beneficiary, value metric, and life cycle accountability. from JAMA Health Forum New Online https://ift.tt/5CprAQv

Improving Clinical Trials Reporting in Medicare Claims

This Viewpoint discusses the challenges of tracking participants and outcomes after clinical trials end and how more accurately reported National Clinical Trial codes would generate substantial value for researchers, patients, and policymakers. from JAMA Health Forum New Online https://ift.tt/KDzSm1u